key: cord-0725217-8w0vd9ub
authors: Mohamed Khosroshahi, Leila; Rezaei, Nima
title: Dysregulation of the immune response in coronavirus disease 2019
date: 2020-12-11
journal: Cell Biol Int
DOI: 10.1002/cbin.11517
sha: 67b54ab6c89d9e370aef804643334673faac1c0f
doc_id: 725217
cord_uid: 8w0vd9ub

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) can trigger a cytokine storm in the pulmonary tissue by releasing various types of mediators, leading to acute respiratory distress syndrome (ARDS). Increased neutrophil‐to‐lymphocyte ratio, as well as CD4+ T lymphopenia, is reported in cases with novel coronavirus disease (COVID‐19), meanwhile, lymphopenia is a significant finding in the majority of COVID‐19 cases with a severe phenotype. Moreover, excessive activation of monocyte/macrophage and cytokine storms are associated with the severity of the disease and the related complications in SARS‐CoV‐2 infection. Understanding the immune response dysregulation in COVID‐19 is essential to develop more effective diagnostic, therapeutic, and prophylactic strategies in this pandemic.

The first patients with pneumonia of an unknown origin were reported in early December 2019 in Wuhan, Hubei province, China. The cause of pneumonia in these cases was a novel beta coronavirus (β CoV) with enveloped RNA that was previously called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) due to the similar phylogenetic with SARS-CoV (Golshani et al., 2020; . The World Health Organization (WHO) has stated that coronavirus disease 2019 (COVID-19) is a public health emergency of pandemic proportions (Guan et al., 2020) . In addition to a huge burden on public health with a high rate of mortality, this pandemic has already distinctly affected the global economy and civil societies (Hanaei & Rezaei, 2020; Jabbari et al., 2020; Momtazmanesh et al., 2020) . The risk of the severe form of the disease is more likely in patients with underlying conditions such as hypertension, cardiovascular disease, and diabetes mellitus Qin et al., 2020) . The virus can trigger a terrible cytokine storm in the pulmonary tissue by releasing various types of mediators causing edema, air exchange dysfunction and acute respiratory distress syndrome (ARDS), acute cardiac injury followed by a secondary infection which may lead to death Xu et al., 2020) . Several studies highlight relevant dysregulation both in innate and adaptive immune systems in COVID-19 patients (Qin et al., 2020) . Dysregulation of the immune response influences the outcome in critical COVID-19 patients. For the development of drugs and vaccines during the epidemic and pandemic outbreak of a new virus, understanding the immune responses against the virus is essential (Lotfi, Hamblin, & Rezaei, 2020; Mansourabadi et al., 2020) . well as T lymphopenia, especially decreased number of CD4 + T cells, was typical in COVID-19 patients, particularly among the severe cases.

However, no significant alteration in the CD8 + cells and B cells was reported, suggesting the lymphocytes impairment, especially T cells immune system dysfunction during the period of illness in COVID-19 (Qin et al., 2020; Wei et al., 2020) . NLR, which is a well-known factor to show systemic infection and inflammation, has been studied as a predictor of bacterial infection including pneumonia (Berhane et al., 2019; X. Liu et al., 2016) . An increased number of neutrophil and a decreased number of lymphocyte were reported in several patients with COVID-19 during the severe phase, indicating a serious disturbance in the internal environment and potential critical condition in those severe infected cases (Fathi & Rezaei, 2020; J. Liu, Wan, et al., 2020) .

The gravity of a viral disease can be determined by direct cytopathic effects exerted by the virus as well as the circumvention of host immune responses (Channappanavar & Perlman, 2017; Min et al., 2016) . A rapid and well-coordinated innate immune response is believed to play a critical role as the first line of defense against viral infections; however, dysregulation of the immune response leads to exacerbated inflammatory responses, even resulting in death (Shaw et al., 2013) . Increased loss of dendritic cell (DC) function could result in delayed T cell responses in COVID-19 patients. DCs play a substantial role in the interaction between innate and adaptive immunity. Plasmacytoid dendritic cell (pDC) is the main potent IFN-I producer against viral infection. Accordingly, the substantial loss of pDC together with a decrease in NK cell could lead to instant destruction of innate immunity against SARS-CoV-2 infection (Chu et al., 2020; R. Zhou et al., 2020) .

Massive upregulation of proinflammatory cytokines and chemokines and CD4 + and CD8 + T cells consumption, as well as reduced regulatory T cells in patients with COVID-19, mainly in the severe illness, may contribute to exacerbated inflammatory responses, the cytokine storm induction, and ultimately aggravated lung injury (Grifoni et al., 2020) . However, correlative evidence from those severe patients with a lower number of lymphocytes reveals the role of dysregulated immune responses in the pathogenesis of COVID-19 (J. Chen et al., 2010; Qin et al., 2020; Rokni et al., 2020) . So, SARS-CoV-2 infection might majorly affect the lymphocytes, especially T cells, and induce a cytokine storm in the body, resulting in several immune responses to impair the corresponding organs. NLR can be served as an independent prognostic marker of disease severity in COVID-19 (Rokni et al., 2020) . In addition, lymphopenia and enhanced NLR are highly correlated with COVID-19 disease severity/ outcome. Therefore, surveillance of NLR and lymphocyte subsets is a useful marker in the early screening of patients and is a specific strategy to diagnose and treat COVID-19 patients (J. Liu, Li, et al., 2020; Qin et al., 2020; ; Figure 1 ).

Lymphopenia is as commonplace as the hematologic abnormality in up to 85% of patients with severe COVID-19 (Qin et al., 2020) . (Qin et al., 2020) . This evidence confirms the movement of inflammatory monocyte/macrophages into the lung tissue and other infected organs. On the other hand, there is a nonspecific finding demonstrating that somewhat larger, vacuolated, and atypical monocytes were observed in the morphological assessment of peripheral blood films of infected patients .

Several studies have proven a remarkable decrease in the total number of natural killer (NK) and CD8 + T cells in COVID-19 patients.

Also, the exhausted activation of NK and CD8 + T cells due to enhanced expression of CD94/NK group 2 member A (NKG2A) was observed in these cases. Notably, the enhanced number of NK and CD8 + T cells was correlated with decreased NKG2A expression after therapy and gradual recovery in patients, suggesting that the functional exhaustion of CTLs is related to SARS-CoV-2 infection (Diao et al., 2020) . Moreover, CD8 + T cells and CD4 + T cells have higher levels of PD-1 and Tim-3, exhaustion markers, in patients (Diao et al., 2020; H.-Y. Zheng et al., 2020) . In the early stages, SARS-CoV-2 infection may break down antiviral immunity (N. Chen et al., 2020; R. Zhou et al., 2020) . Importantly, the effects of NKG2A expression on NK and CD8 + T cells activation lead to functional depletion of NK and CTLs. According to results, NKG2A expression was upregulated on NK cells and CD8 + T cells in COVID-19 patients with a reduced ability to produce CD107a, granzyme B, IFN-γ, and TNF-α (Haanen & Cerundolo, 2018) .

The number of NKG2A + cytotoxic lymphocytes was also reduced in 

The complement system plays a pivotal role in the host immune response to COVID-19. Complement activation was also observed in COVID-19 patients, which might be involved in the pathogenesis of severe lung injury and ARDS. Furthermore, complement activation may contribute to the maladaptive inflammatory and immune response rather than increased viral loads seen in some patients with acute COVID-19 (Guan et al., 2020; .

The virus uses virus-encoded proteins to avoid being detected by the complement system, emphasizing the critical role of complements in antiviral responses. C3a and C5a with potential characteristics of proinflammatory factors are able to initiate the recruitment of inflammatory cells and activate neutrophils (Gralinski et al., 2018) .

As a curative approach to acute lung injury, the obstruction of C3a and C5a has been proved to be fruitful. Anti-C5a antibody was reported to mitigate the gravity of the adverse impacts arising from MERS-CoV in mice (Gralinski et al., 2018; Sun et al., 2013) . In a study by Gao et al. (2020) N proteins were shown to empower SARS-CoV-2 to attach to mannose-associated serine protease 2 (MASP-2).

MASP-2 is a key serine protease in the lectin pathway of complement activation, resulting in aberrant C5 activation and aggravated inflammatory lung injury. The complement cascade is activated during SARS-CoV-2 and participates in the pathogenesis of the disease Sun et al., 2013) .

SARS-CoV-2 can evade the immune responses, which permits the virus to produce enormous copy numbers in infected tissues.

Through the dysregulation and infection of the immune cells as well as the recruitment of other immune cells from the circulation to the site of infection, acute immune reactions induce inflammation resulting in a cytokine storm and life-menacing problems (Schurink et al., 2020; Yazdanpanah et al., 2020) . Dysregulation of host immunity, including hyper-activation of macrophage and complement system, NLR induction, as well as NK cells and CTLs exhaustion, could be involved in the disease severity and outcomes. Understanding of the immune system dysregulation seems to be critical for disease control in patients with COVID-19.

The authors declare that there are no conflict of interests.

N. R. proposed the general concept and supervised the project. L. M.

K. contributed to the data gathering, writing the manuscript, and preparing the figure, while N. R. contributed to study design, scientific, and structural editing. N. R. and L. M. K. critically revised the manuscript. Both authors approved the final draft of the manuscript before submission.

Data sharing is not applicable to this article as no new data were created or analyzed in this study.

Nima Rezaei http://orcid.org/0000-0002-3836-1827

Dysregulation of type I interferon responses in COVID-19

Viral persistence and chronicity in hepatitis C virus infection: Role of T-cell apoptosis, senescence, and exhaustion

The role of neutrophil to lymphocyte count ratio in the differential diagnosis of pulmonary tuberculosis and bacterial community-acquired pneumonia: A cross-sectional study at Ayder and Mekelle hospitals

Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice

Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology

Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection

Epidemiological and clinical characteristics of 99 cases of

A descriptive study. The Lancet

Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: An ex vivo study with implications for the pathogenesis of COVID-19

Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)

SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-κB pathway in human monocyte macrophages in vitro

Lymphopenia in COVID-19: Therapeutic opportunities

A tug-ofwar between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses. Emerging microbes & infections

Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation

Complex immune dysregulation in COVID-19 patients with severe respiratory failure

SARS-CoV-2-a tough opponent for the immune system

Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis

Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals

Clinical characteristics of coronavirus disease 2019 in China

NKG2A, a new kid on the immune checkpoint block

COVID-19: Developing from an outbreak to a pandemic

SARS-CoV regulates immune function-related gene expression in human monocytic cells

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

COVID-19: A chimera of two pandemics

Coronavirus infections and immune responses

The landscape of lung bronchoalveolar immune cells in COVID-19 revealed by single-cell RNA sequencing

Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2

Nanomedicine therapies modulating macrophage dysfunction: A potential strategy to attenuate cytokine storms in severe infections

Prognostic significance of neutrophil-to-lymphocyte ratio in patients with sepsis: A prospective observational study

COVID-19: Transmission, prevention, and potential therapeutic opportunities

SARS-CoV-2: A comprehensive review from pathogenicity of the virus to clinical consequences

The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19

Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity

All together to fight novel coronavirus disease (COVID-19)

Dysregulation of immune response in patients with COVID-19 in Wuhan, China

Comparison of clinical, para-clinical and laboratory findings in survived and deceased patients with COVID-19: Diagnostic role of inflammatory indications in determining the severity of illness

Immune-epidemiological parameters of the novel coronavirus -a perspective

Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids

Severe COVID-19 is marked by a dysregulated myeloid cell compartment

Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study

Age-dependent dysregulation of innate immunity

Inhibition of complement activation alleviates acute lung injury induced by highly pathogenic avian influenza H5N1 virus infection

Dysregulation of the immune response affects the outcome of critical COVID-19 patients

Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet respiratory medicine

A pathological report of three COVID-19 cases by minimally invasive autopsies

The immune system and COVID-19: Friend or foe?

COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes, the severity of which correlate with patient outcome. medRxiv

Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients

Functional exhaustion of antiviral lymphocytes in COVID-19 patients

Acute SARS-CoV-2 infection impairs dendritic cell and T cell responses

Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients

Dysregulation of the immune response in coronavirus disease 2019